Position in ARQT
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$6,044,200
-$777,731 QoQ
Shares Held
256,545
+9.2% QoQ
Ownership
0.205%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 99.57122532109378.ToString("F0")%
Shared 0.ToString("F0")%
None 0.4287746789062348.ToString("F0")%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRUDENTIAL FINANCIAL INC holds $507,759,030 across 170 Biotechnology names. ARQT ranks #18 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,491 | $108,548,965 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
131,560 | $58,746,801 | |
| 3 | INCY |
Incyte Corp
|
374,280 | $35,227,233 | |
| 4 | EXEL |
Exelixis, Inc.
|
463,825 | $19,893,454 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
64,133 | $12,804,153 | |
| 6 | ALMS |
Alumis Inc.
|
538,733 | $11,868,287 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
164,570 | $11,212,154 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
95,235 | $10,037,769 |
All Filings in ARQT
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,044,200 | 256,545 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $6,821,931 | 234,915 | Shares | Defined | 2026-02-13 | |
| 2025-12-31 | $205,601,051 | 7,079,926 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $262,674 | 13,935 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $8,396,578 | 598,900 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $9,277,569 | 593,195 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $8,254,430 | 592,565 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $5,325,319 | 572,615 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,325,319 | 572,615 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $7,168,150 | 723,325 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,642,317 | 818,055 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,929,733 | 363,415 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,463,344 | 363,415 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,791,130 | 162,830 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,433,454 | 96,855 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,277,216 | 66,835 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $1,417,008 | 66,495 | Shares | Defined | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||